Microsoft Brings AI to U.K. Gene-Therapy Firm

Software giant Microsoft Corp. is working with U.K. biotechnology firm Oxford Biomedica Plc on developing better ways of repairing the genes of people with life-threatening diseases. - Bloomberg

Innovator and leader in molecular and genetic programming